Home
•
Industry Projects
•
RAD001 – Anti-Cancer Therapy
•
Image 3
RAD001 – Anti-Cancer Therapy
Print
The lungs and soft tissues are the most common secondary sites of RCC.
«Back
Return to Project
Home
|
New On This Site
|
Products & Services
|
Company A-Z
|
Industry Projects
|
White Papers
|
Jobs & Careers
|
Press Releases
|
Events & Exhibitions
|
Newsletter
|
Organisations
|
About Us
|
Contact Us
|
Advertise With Us
|
Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area
What is RSS
For every phase of your drug development
Search
